Environmental And Chemical Toxins And Psychiatric Illness

During the past 60 years, the number of chemical disasters worldwide from military, occupational, and environmental sources has risen at an alarming rate. The profound controversy surrounding many chemicals makes objective analysis nearly impossible. Yet now more than ever -- with the daily exposure to a wide range of chemicals and the increased threat of chemical terrorism -- it is critical that we understand the role of chemicals in causing psychiatric illness. Unlike related books, this remarkable reference is intended specifically for psychiatric applications and is thus the definitive sourcebook for the many professionals called on to respond to these events. This work stands alone as the first on this topic to be written by a psychiatrist and the first to bring together the military, occupational, and environmental exposures causing psychiatric illness, including multiple chemical sensitivities, mass hysteria, radiation exposures, community stress reactions, and Gulf War and other syndromes. Unique highlights include A summary of the reported psychiatric symptoms attributed to each chemical class (chemical weapons, pesticides, fumigants, metals, solvents, gases, PCBs, Agent Orange, and other miscellaneous chemicals) in tables for easy reference. We use personal care products, take prescription drugs, pump gasoline, drink alcohol, and spray insecticides as part of our everyday lives. Yet rarely do we realize that significant exposures to the chemicals described in this book -- many of which we are exposed to in daily activities -- can damage the central nervous system, causing psychiatric illness. A comprehensive bibliography, in every chapter, of all the important material in English-language medical journals and books that has appeared on this subject since the late 19th century. These bibliographies cover everything from the first published reports of the dangers of carbon disulfide in the French rubber industry -- dangers that American medicine ignored for years -- through more recent large-scale chemical exposures that have serious long-term consequences. (e.g., Love Canal). The latest information about terrorist and military uses of chemical weapons -- of critical relevance in psychiatry today -- from World War I combatants exposed to chlorine, phosgene, mustard gas, arsenic, and cyanide to the first organophosphate, or nerve, gases (such as tabun and sarin) developed by the Germans before and during World War II (and used by Iraq in the Gulf War and by a religious cult in the terrorist subway attacks in Tokyo and Matsumoto, Japan). Quite simply, this book is a "must have" for psychiatric and medical professionals everywhere, with extended appeal among laypersons such as environmental/consumer advocates, attorneys, insurance professionals, industrial hygienists, disaster planners, and medical librarians.

Environmental illness: certain health professionals and clinical ecologists claim it impacts and inhibits 15 percent of the population. Its afflicted are led to believe environmental illness (EI) originates with food, chemicals, and other stimuli in their surroundings -as advocates call for drastic measures to remedy the situation. What if relief proves elusive-and the patient is sent on a course of ongoing, costly and ineffective "treatment"? Several hundred individuals who believed they were suffering from EI have been evaluated or treated by Herman Staudenmayer since the 1970s. Staudenmayer believed the symptoms harming his patients actually had psychophysiological origins-based more in fear of a hostile world than any suspected toxins contained in the environment. Staudenmayer's years of research, clinical work-and successful care-are now summarized in Environmental Illness: Myth & Reality. Dismissing much of the information that has attempted to defend EI and its culture of victimization, Staudenmayer details the alternative diagnoses and treatments that have helped patients recognize their true conditions-and finally overcome them, often after years of prolonged suffering.

Examines what we know about the relationship between organic chemicals and human disease Organic chemicals are everywhere: in the air we breathe, the water we drink, and the food we eat. They are also found in a myriad of common household and personal care products. Unfortunately, exposure to some organic chemicals can result in adverse health effects, from growth and developmental disorders to cancer and neurodegenerative diseases. This book examines how organic chemicals affect human health. It looks at the different diseases as well as how individual organ systems are affected by organic chemicals. Effects of Persistent and Bioactive Organic Pollutants on Human Health begins with an introductory chapter explaining why we should care about organic chemicals and their effect on human health. Next, the authors address such important topics as: Burden of cancer from organic chemicals Organic chemicals and obesity Effects of organic chemicals on the male reproductive system Organic chemicals and the immune system Intellectual developmental disability syndromes and organic chemicals Mental illness and exposure to organic chemicals The book ends with an assessment of how much human disease is caused by organic chemicals. Chapters have been contributed by leading international experts in public and environmental health and are based on the latest research findings. Readers will find that all of the contributions are clear and easy to comprehend, with extensive references for further investigation of individual topics. Effects of Persistent and Bioactive Organic Pollutants on Human Health is recommended for students and professionals in medicine as well as public and environmental health, bringing them fully up to date with what we know about the relationship between organic chemicals and human health.

Environmental illness is a concept of growing concern to all health professionals. Patients with problems presumably caused by sick buildings, electromagnetic fields and hypersensitivity to chemicals--to name a few--are often referred to psychologists, psychiatrists, and other counselors. The battery worker with fatigue, headaches, abdominal pain and an elevated lead level...the assembly worker with pain and numbness in her hand and delayed median nerve conduction...the patient who develops typical contact dermatitis after working with epoxies..., these are straightforward cases. But they are in the minority. In many cases, needy, demanding, and difficult patients present complex and challenging psychological issues. Practitioners often lack the training or wisdom to handle these issues effectively. We know that exposure to lead, mercury, and PCBs affect psychological development and behavior; we know much less about the effects of thousands of other chemicals in the environment. In addition, global climate change, social disruption, and the spread of infections will--in the near future--expose people to novel environmental threats. Symptoms caused by toxins can overlap those caused by fear, stress, and depression, and the clinical picture can mimic a variety of other mental disorders. On the other hand, the natural environment can also be a healer. Research shows that hospital stays are shortened and the need for pain medication reduced for patients exposed to nature, even in images, or to the company of animals. Nursing home patients live longer if allowed to keep pets, and one controlled study shows that caring for animals reduces disruptive behavior in even the most difficult ADD children. This book offers the first overview of the many ways the environment can affect mental health and illness. It will prove to be an important and valuable resource for physicians in psychiatry, public health, and environmental medicine; for clinical and counseling psychologists and social workers; and for environmental researchers and advocates worldwide.

Scientists agree that exposure to toxic agents in the environment can cause neurological and psychiatric illnesses ranging from headaches and depression to syndromes resembling parkinsonism. It can even result in death at high exposure levels. The emergence of subclinical neurotoxicity-the concept that long-term impairments can escape clinical detection-makes the need for risk assessment even more critical. This volume paves the way toward definitive solutions, presenting the current consensus on risk assessment and environmental toxicants and offering specific recommendations. The book covers: The biologic basis of neurotoxicity. Progress in the application of biologic markers. Reviews of a wide range of in vitro and in vivo testing techniques. The use of surveillance and epidemiology to identify neurotoxic hazards that escape premarket screening. Research needs. This volume will be an important resource for policymakers, health specialists, researchers, and students.

The United States is among the wealthiest nations in the world, but it is far from the healthiest. Although life expectancy and survival rates in the United States have improved dramatically over the past century, Americans live shorter lives and experience more injuries and illnesses than people in other high-income countries. The U.S. health disadvantage cannot be attributed solely to the adverse health status of racial or ethnic minorities or poor people: even highly advantaged Americans are in worse health than their counterparts in other, "peer" countries. In light of the new and growing evidence about the U.S. health disadvantage, the National Institutes of Health asked the National Research Council (NRC) and the Institute of Medicine (IOM) to convene a panel of experts to study the issue. The Panel on Understanding Cross-National Health Differences Among High-Income Countries examined whether the U.S. health disadvantage exists across the life span, considered potential explanations, and assessed the larger implications of the findings. U.S. Health in International Perspective presents detailed evidence on the issue, explores the possible explanations for the shorter and less healthy lives of Americans than those of people in comparable countries, and recommends actions by both government and nongovernment agencies and organizations to address the U.S. health disadvantage.

Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.

Diseases of the kidney, bladder, and prostate exact an enormous human and economic toll on the population of the United States. This book examines prevention of these diseases through the development of reliable markers of susceptibility, exposure, and effect and the promise that new technologies in molecular biology and sophisticated understanding of metabolic pathways, along with classical approaches to the study of nephrotoxicants and carcinogens, can be developed and prevention of the diseases achieved. The specific recommendations included in this book complement those made in the previous three volumes on biomarkers, Biologic Markers in Reproductive Toxicology (1989), Biologic Markers in Pulmonary Toxicology (1989), and Biologic Markers in Immunotoxicology (1991).